Tag: Hepatitis
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer
Findings seen for patients receiving direct-acting antivirals with complete response to liver cancer treatment
USPSTF Reaffirms Benefit of Hep B Screening in Pregnant Women
USPSTF continues to recommend screening for HBV infection in pregnant women at the first prenatal visit
Parkinson Disease Incidence Lower in Hep C Patients Who Receive Antivirals
Advantage of interferon-based antiviral therapy reached statistical significance at five-year follow-up
CDC: Hepatitis A Virus Reports Increased in 2016 to 2018
Multiple infection outbreaks among those reporting drug use, homelessness account for most reports
FDA Approves Mavyret for Children, Adolescents With Hep C
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
High Response Seen for All Hep C Tx Models in Injection Drug Users
Directly observed therapy tied to greater adherence than self-administered individual treatment
Heart, Lungs From Hep C-Infected Donor Can Be Transplanted Safely
Transplant into patients without HCV infection feasible, with excellent function at six months
HBV, HCV Control Aids Kidney Transplant Outcomes
Patients with viral suppression have outcomes similar to those of noninfected patients
Direct-Acting Antivirals Cut Mortality in Chronic Hepatitis C
Mortality, hepatocellular carcinoma risk reduced after adjustment for potential confounders
Hepatitis C Infection Rates Up After OxyContin Reformulation
222 percent increase in HCV infection rates seen after reformulation in states with above-median misuse
